CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors

被引：0
|
作者：
Zhe Huang
Ping Ping Zhou
Shan Shan Li
Kaiyan Li
机构：
[1] Huazhong University of Science and Technology,Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College
来源：
Cancer Imaging | / 23卷
关键词：
Contrast-Enhanced Ultrasound; Hepatocellular carcinoma; Risk factors; Diagnosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Standardizing diffusion-weighted imaging in LI-RADS for diagnosis of hepatocellular carcinoma
    Scialpi, Michele
    Evangelisti, Arianna
    Shehu, Klesta
    Comite, Paola
    Antogiovanni, Giuseppe Nazareno
    Scalera, Giovanni Battista
    EUROPEAN RADIOLOGY, 2025, 35 (02) : 695 - 697
  • [32] Risk of Hepatocellular Carcinoma in Patients With Indeterminate (LI-RADS 3) Liver Observations
    Arvind, Ashwini
    Joshi, Sagar
    Zaki, Timothy
    Burkholder, Daniel
    Parikh, Neehar D.
    Singal, Amit G.
    North Amer Liver Canc NALC Consortium
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (04) : 1091 - +
  • [33] Diagnosis of Hepatic Nodules in Patients at Risk for Hepatocellular Carcinoma: LI-RADS Probability Versus Certainty
    Bruix, Jordi
    Ayuso, Carmen
    GASTROENTEROLOGY, 2019, 156 (04) : 860 - 862
  • [34] RISK OF PROGRESSION TO HEPATOCELLULAR CARCINOMA IN PATIENTS WITH INDETERMINATE (LI-RADS 3) OBSERVATIONS
    Arvind, Ashwini
    Zaki, Timothy A.
    Yokoo, Takeshi
    Fetzer, David T.
    Browning, Travis
    Rich, Nicole E.
    Marrero, Jorge A.
    Zhu, Hao
    Yopp, Adam
    Hoshida, Yujin
    Gopal, Purva
    Parikh, Neehar D.
    Singal, Amit G.
    GASTROENTEROLOGY, 2021, 160 (06) : S759 - S760
  • [35] The Value of CEUS LI-RADS combined with AFP in early diagnosis of hepatocellular carcinoma in low- and high-risk patients
    Wu, Yafei
    Chen, Yuanyuan
    Wei, Lili
    Ding, Zhanling
    Zhao, Shengfa
    Bao, Shengxian
    Tang, Jiali
    Li, Hang
    Liu, Junjie
    Zhu, Shangyong
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (04) : 1274 - 1283
  • [36] LI-RADS US Surveillance Version 2024 for Surveillance of Hepatocellular Carcinoma: An Update to the American College of US LI-RADS
    Kamaya, Aya
    Fetzer, David T.
    Seow, James H.
    Burrowes, David P.
    Choi, Hailey H.
    Dawkins, Adrian A.
    Fung, Christopher
    Gabriel, Helena
    Hong, Cheng William
    Khurana, Aman
    Mcgillen, Kathryn L.
    Morgan, Tara A.
    Sirlin, Claude B.
    Tse, Justin R.
    Rodgers, Shuchi K.
    RADIOLOGY, 2024, 313 (03)
  • [37] Increased interreader agreement in diagnosis of hepatocellular carcinoma using an adapted LI-RADS algorithm
    Becker, Anton S.
    Barth, Borna K.
    Marquez, Paulo H.
    Donati, Olivio F.
    Ulbrich, Erika J.
    Karlo, Christoph
    Reiner, Caecilia S.
    Fischer, Michael A.
    EUROPEAN JOURNAL OF RADIOLOGY, 2017, 86 : 33 - 40
  • [38] Role of Kupffer phase image using sonazoid on CEUS LI-RADS® and diagnostic performance for hepatocellular carcinoma
    Hwang, Jeong Ah
    Jeong, Woo Kyoung
    Min, Ji Hye
    Kim, Yeun-Yoon
    Lim, Hyo K.
    JOURNAL OF HEPATOLOGY, 2020, 73 : S535 - S535
  • [39] Clinical predictors of radiographic progression of a hepatic lesion from Li-RADS 3 to Li-RADS 5 among a population of individuals at high risk of hepatocellular carcinoma.
    Hannan, Lindsay Marie
    Ojeda, Patricia I.
    Hippe, Daniel S.
    Mieloszyk, Rebecca
    Johnson, Guy E.
    Harris, William Proctor
    Bhargava, Puneet
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Reply to "Standardizing diffusion-weighted imaging in LI-RADS for diagnosis of hepatocellular carcinoma"
    Cannella, Roberto
    Zins, Marc
    Brancatelli, Giuseppe
    EUROPEAN RADIOLOGY, 2025, 35 (02) : 698 - 699
12345